Literature DB >> 2677563

Innominate artery compression of the trachea: current concepts.

C M Myer1, B J Wiatrak, R T Cotton, K E Bove, W W Bailey.   

Abstract

One common vascular anomaly that causes airway obstruction in neonates and infants is innominate artery compression of the trachea. A great deal of controversy exists regarding the effect of this anatomic variant on symptom production. Several cases are presented that demonstrate the unique features of innominate artery compression of the trachea: 1. Innominate artery compression can occur in adolescent patients. 2. Flow volume loops are an effective method of documenting airway compromise in this condition. 3. Exercise intolerance should be considered as a relative indication for surgical intervention in these patients. 4. Reimplantation of the innominate artery is a viable surgical alternative in the treatment of affected patients. 5. Telescopic bronchoscopy during surgical correction of this condition will ensure that there has been successful correction of the tracheal compression. 6. Urgent repair is advocated in patients who experience periods of apnea.

Entities:  

Mesh:

Year:  1989        PMID: 2677563     DOI: 10.1288/00005537-198210000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Intraoperative airway obstruction in a Duchenne muscular dystrophy patient.

Authors:  Jae Hyuk Yang; Amit Wasudeo Bhandarkar; Byung Gun Lim; Hitesh N Modi; Seung Woo Suh
Journal:  Eur Spine J       Date:  2013-03-17       Impact factor: 3.134

2.  Airway obstruction by extrinsic tracheal compression during spinal surgery under prone position -A case report-.

Authors:  Rak Min Choi; Jin Sun Yoon; Jae Hoon Noh; Kyoung Oh Kang; Sang Wook Ryu; Hee Jung Jun; Sam Soon Cho
Journal:  Korean J Anesthesiol       Date:  2010-12-31

Review 3.  The Management of Cyanotic Spells in Children with Oesophageal Atresia.

Authors:  Mathieu Bergeron; Aliza P Cohen; Robin T Cotton
Journal:  Front Pediatr       Date:  2017-05-15       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.